TANNOLACT Creme, 50 g

Instructions for use for TANNOLACT Creme, 50 g

Detailed instructions for TANNOLACT Creme, 50 g

Field of use

• The medicine is a tannin preparation with anti -inflammatory and itching effect that is intended for use on the skin.
• The medicine is used for the supportive treatment of skin diseases associated with inflammation, moisture and itching.

Active ingredients / ingredients / ingredients

10 mg phenolsulfonic acid phenol urea for formaldehyde condensate, sodium salt
Butylhydroxyanisol Hedge substance (+)
Cetylstearyl alcohol auxiliary material (+)
Dimeticon 350 Hedge substance (+)
Paraffin, thin -fluid auxiliary material (+)
Polysorbate 60 HILDVERSTOFT (+)
Propylen glycol auxiliary substance (+)
Sorbitan stairs auxiliary substance (+)
Water, cleaned auxiliary material (+)
Sorbic acid auxiliary material (+)

Contradictions

• The medicine must not be used:
  • if you are hypersensitive (allergic) against synthetic tannins or one of the other components of the drug
  • on the eye

dosage

• Always apply the medicine exactly according to the instruction. Please ask your doctor or pharmacist if you are not quite sure.
• The drug may only be used externally!
• Unless otherwise prescribed by the doctor, the usual dose is:
  • Apply Tannosynt to the diseased skin up once a day until healing.
• Please speak to your doctor or pharmacist if you have the impression that the effect is too strong or too weak.
• If you have any further questions about the application of the drug, ask your doctor or pharmacist.

Taking

• May only be used externally!
• Apply the medicine to the diseased skin up to healing once or twice a day.

Patient information

• Wateriness and operating machines
  • There are no special precautions required.

Pregnancy

• Ask your doctor or pharmacist for advice before taking/using all drugs.
• There are no concerns about the application during pregnancy and breastfeeding, since there is no absorption via the skin into the body.

Hints

Miscellaneous

- There are no experience for using children and adolescents under the age of 18.